GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $11.87 $15.18 Friday, 19th Apr 2024 ASMB stock ended at $13.41. This is 0.600% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.98% from a day low at $13.24 to a day high of $13.90.
90 days $0.82 $15.18
52 weeks $0.641 $15.18

Historical Assembly Biosciences prices

Date Open High Low Close Volume
2024-04-19 $13.69 $13.90 $13.24 $13.41 11 270
2024-04-18 $12.95 $13.33 $12.40 $13.33 16 689
2024-04-17 $14.80 $14.80 $12.55 $12.92 26 429
2024-04-16 $14.65 $14.96 $14.35 $14.52 7 400
2024-04-15 $14.66 $15.18 $14.55 $14.93 17 358
2024-04-12 $14.97 $15.00 $14.59 $14.65 19 380
2024-04-11 $14.35 $15.07 $14.35 $15.06 13 918
2024-04-10 $14.78 $14.99 $14.51 $14.68 8 353
2024-04-09 $14.42 $14.99 $14.20 $14.85 26 414
2024-04-08 $14.04 $14.70 $14.04 $14.40 17 966
2024-04-05 $13.64 $14.50 $13.41 $13.77 20 464
2024-04-04 $13.99 $14.23 $13.36 $13.64 26 696
2024-04-03 $13.33 $14.35 $13.26 $13.79 41 050
2024-04-02 $13.15 $13.50 $12.80 $13.50 37 029
2024-04-01 $13.30 $13.30 $12.90 $12.90 18 808
2024-03-28 $13.15 $13.45 $13.02 $13.30 30 110
2024-03-27 $13.13 $13.40 $12.73 $13.38 21 473
2024-03-26 $13.35 $13.40 $12.71 $13.06 19 950
2024-03-25 $12.80 $13.39 $12.66 $13.20 35 651
2024-03-22 $12.37 $12.98 $12.16 $12.98 20 409
2024-03-21 $12.08 $12.69 $12.08 $12.20 21 777
2024-03-20 $11.87 $12.39 $11.87 $12.39 7 165
2024-03-19 $11.81 $12.16 $11.79 $11.83 9 915
2024-03-18 $12.05 $12.10 $11.60 $11.80 9 604
2024-03-15 $11.97 $12.17 $11.75 $12.17 16 159
Click to get the best stock tips daily for free!

About Assembly Biosciences

Assembly Biosciences Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical tri... ASMB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT